IRICoR is proud to announce, as part of his joint project with the Oncopole, LeadAction Onco, an investment of $2.4 million dollars over two years, to support four flagship cancer drug discovery projects in Canada. This major announcement was made today by Mr. Pierre Fitzgibbon, Minister of Economy and Innovation, on the occasion of the opening of the Quebec Pavilion […]
IRICoR is pleased to announce the appointment of three new Directors to its Board: Ms. Annie Gauthier – lawyer and partner at the law firm BCF, Bettina Hamelin – President and CEO of Ontario Genomics and Mr. Bernard Lachapelle – President of The JBL Group Inc.
These three new Directors bring a range of expertise complementary to that […]
The Technology Transfer Career Training Program provides an opportunity to transition to a career in technology transfer that includes formal training, networking, and practical experience in this field.
The program pairs selected applicants with an experienced technology transfer mentor who offers in-depth, first-hand knowledge of the complexities of the profession. Fellows follow a core syllabus of educational webinars covering such […]
First of a series of interviews with Scholarship Competition – Entrepreneurship in Oncology (CEO) recipients
Discussion with Simon Beaudoin, participant of the first cohort of the Life Sciences Entrepreneurship Development Program. Simon is founder and CEO of WASSC Technologie and holds a post-doctoral degree from the Université de Sherbrooke.
How did you hear about the Life Sciences Entrepreneurship Development Program and what made you want to participate?
It was the year I wanted to commercialize my patent […]
IRICoR proudly announces the hiring of Jean-Louis Brochu, new Senior Manager, Intellectual Property.
IRICoR is pleased to welcome Mr. Jean-Louis Brochu to its team as Senior Intellectual Property Manager. In this role, Mr. Brochu will be responsible for crafting intellectual property (IP) strategies adapted to the development of each portfolio project, coordinating and contributing to the drafting of patent applications in collaboration with researchers and patent agent from external firms, and guiding IRICoR’s […]
MONTREAL, April 29, 2019 /CNW Telbec/ – IRICoR is proud to be one of 14 partners who contributed to the first edition of the EFFERVESCENCE – The future of life sciences event, held on April 24th and 25th at TOHU. This major event, developed for the Life Sciences and Health Technologies sector, is undoubtedly the new business meeting not-to-be-missed for all of the key players in the field.
Scientific and […]
IRICoR is pleased with the announcement made by ExCellThera, a clinical stage biotechnology company, which is result of its collaboration with the Center for Commercialization of Regenerative Medicine (CCRM), regarding the clearance by FDA and Health Canada for two new clinical trials for using its innovative ECT-001 technology in the treatment of leukemia.
ExCellThera designs product and service solutions based on […]